Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2002 May;93(5):532–541. doi: 10.1111/j.1349-7006.2002.tb01288.x

Hepatocyte Nuclear Factor (HNF)‐4α Induces Expression of Endothelial Fas Ligand (FasL) to Prevent Cancer Cell Transmigration: A Novel Defense Mechanism of Endothelium against Cancer Metastasis

Makoto Osanai 1,3,✉, Hideki Chiba 1, Takashi Kojima 1, Masato Fujibe 1, Kazuhide Kuwahara 1, Hiromichi Kimura 2, Masaaki Satoh 1, Norimasa Sawada 1
PMCID: PMC5927027  PMID: 12036449

Abstract

Endothelial Fas ligand (FasL) contributes to the “immune privilege” of tissues such as testis and eye, in which apoptosis is induced in infiltrating Fas‐positive activated T cells and results in the inhibition of leukocyte extravasation. In this study, we examined the role of endothelial FasL in controlling cancer cell transmigration using rat lung endothelial (RLE) cell line bearing a doxycycline‐inducible hepatocyte nuclear factor (HNF)‐4α expression system. We showed that a detectable level of FasL was expressed in RLE cells and that this expression was markedly up‐regulated and well correlated to the degree of HNF–4α expression in a time‐dependent manner. When various cancer cells were overlaid on an RLE monolayer sheet, we examined the ability of endothelial FasL to induce massive apoptosis in Fas‐expressing cancer cells and found a causal link to inhibition of the transmigration. Finally, we showed that FasL was expressed in capillaries of the rat brain by immunohistochemical staining, suggesting that FasL serves its functions not only in vitro, but also in vivo. These results raise the possibility that HNF–4α is involved in regulating cancer cell transmigration by modulating the Fas‐FasL system.

Keywords: Fas ligand, Hepatocyte nuclear factor–4α, Endothelial cell, Apoptosis, Transmigration

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

REFERENCES

  • 1. ) Ross , R.The pathogenesis of atherosclerosis: a perspective for the 1990s . Nature , 362 , 801 – 809 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Price , J. E. , Aukerman , S. L. and Fidler , I. J.Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements . Cancer Res. , 46 , 5172 – 5178 ( 1986. ). [PubMed] [Google Scholar]
  • 3. ) Fidler , I. J.Critical factors in the biology of human cancer metastasis: twenty‐eighth G.H.A. Clowes Memorial Award Lecture . Cancer Res. , 50 , 6130 – 6138 ( 1990. ). [PubMed] [Google Scholar]
  • 4. ) Nagata , S. and Golstein , P.The Fas death factor . Science , 267 , 1449 – 1456 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Nagata , S.Apoptosis by death factor . Cell , 88 , 355 – 365 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Krammer , P. H. , Dhein , J. , Walczak , H. , Behrmann , I. , Mariani , D. , Matiba , B. , Fath , M. , Daniel , P. T. , Knipping , E. and Wastendrop , M. O.The role of APO–1–mediated apoptosis in the immune system . Immunol. Rev. , 142 , 175 – 191 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Suda , T. , Takahashi , T. , Golstein , P. and Nagata , S.Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family . Cell , 75 , 1169 – 1178 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Oehm , A. , Behrmann , I. , Falk , W. , Pawlita , M. , Maiser , G. , Klas , C. , Li‐Weber , M. , Richards , S. , Dhein , J. , Trauth , B. C. and Krammer , P. H.Purification and molecular cloning of the APO–1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor family: sequence identity with the Fas antigen . J. Biol. Chem. , 267 , 10709 – 10715 ( 1992. ). [PubMed] [Google Scholar]
  • 9. ) Itoh , N. , Yonehara , S. , Ishii , A. , Yonegara , M. , Mizushita , S. , Sameshita , M. , Hase , A. , Seto , Y. and Nagata , S.The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis . Cell , 66 , 233 – 243 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Krammer , P. H. , Behrmann , I. , Daniel , P. , Dhein , J. and Debatin , K. M.Regulation of apoptosis in the immune system . Curr. Opin. Immunol. , 6 , 279 – 289 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Lowin , B. , Hahne , M. , Mattmann , C. and Tschopp , J.Cytolytic T‐cell cytotoxicity is mediated through perforin and Fas lytic pathways . Nature , 370 , 650 – 652 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Watanabe‐Fukunaga , R. , Brannan , C. I. , Copeland , N. G. , Jenkins , N. A. and Nagata , S.Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis . Nature , 356 , 314 – 317 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Takahashi , T. , Tanaka , M. , Brannan , C. I. , Jenkins , N. A. , Copeland , N. G. , Suda , T. and Nagata , S.Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand . Cell , 76 , 969 – 976 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Fisher , G. H. , Rosenberg , F. J. , Straus , S. E. , Dale , J. K. , Middleton , L. A. , Lin , A. Y. , Strober , W. , Lenardo , M. J. and Puck , J. M.Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome . Cell , 81 , 935 – 946 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Leithäuser , F. , Dhein , J. , Mechtersheimer , G. , Koretz , K. , Bruderlein , S. , Henne , C. , Schmidt , A. , Debatin , K. M. , Krammer , P. H. and Moller , P.Constitutive and induced expression of APO–1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in neural and neoplastic cells . Lab. Invest. , 69 , 415 – 429 ( 1993. ). [PubMed] [Google Scholar]
  • 16. ) Nagata , S.Fas ligand and immune evasion . Nat. Med. , 2 , 1306 – 1317 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Griffith , T. S. , Brunner , T. , Fletcher , S. M. , Green , D. R. and Feruguson , T. A.Fas ligand‐induced apoptosis as a mechanism of immune privilege . Science , 270 , 1189 – 1192 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Bellgrau , D. , Gold , D. , Selawry , H. , Moore , J. , Franzusoff , A. and Duke , R. C.A role for CD95 ligand in preventing graft rejection . Nature , 377 , 630 – 632 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Stuart , P. M. , Griffith , T. S. , Usui , N. , Pepose , J. , Yu , X. and Feruguson , T. A.CD95 ligand (FasL)‐induced apoptosis is necessary for corneal allograft survival . J. Clin. Invest. , 99 , 396 – 402 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Strand , S. , Hofmann , W. J. , Hug , H. , Muller , M. , Otto , G. , Strand , D. , Mariani , S. M. , Stremmel , W. and Krammer , P. H.Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand‐expressing tumor cells: a mechanism of immune evasion ? Nat. Med. , 2 , 1361 – 1366 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Hahne , M. , Rimoldi , D. , Schroter , M. , Romero , P. , Schreier , M. , French , L. E. , Schneider , P. , Bornand , T. , Fontana , A. , Lienard , D. , Cerottini , J. and Tschopp , J.Melanoma cell expression of Fas (APO–1/CD95) ligand: implications for tumor immune escape . Science , 274 , 1363 – 1366 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Sata , M. and Walsh , K.TNFα regulation of Fas ligand expression on the vascular endothelium mediates leukocyte extravasation . Nat. Med. , 4 , 415 – 420 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Sladek , F. M. , Zhong , W. M. , Lai , E. and Darnell , J. E. , Jr.Liver‐enriched transcription factor HNF–4 is a novel member of the steroid hormone receptor superfamily . Genes Dev. , 4 , 2353 – 2365 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Drewes , T. , Senkel , S. , Holewa , B. and Ryffel , G. U.Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes . Mol. Cell. Biol. , 16 , 925 – 931 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. ) Späth , G. F. and Weiss , M. C.Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells . Mol. Cell. Biol. , 17 , 1913 – 1922 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Hu , C. and Perlmutter , D. H.Regulation of alphal‐antitrypsin gene expression in human intestinal epithelial cell line Caco–2 by HNF‐lalpha and HNF–4 . Am. J. Physiol. , 276 , G1181 – G1194 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Späth , G. F. and Weiss , M. C.Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells . J. Cell Biol. , 140 , 935 – 946 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Li , J. , Ning , G. and Duncan , S. A.Mammalian hepatocyte differentiation requires the transcription factor HNF–4alpha . Genes Dev. , 14 , 464 – 474 ( 2000. ). [PMC free article] [PubMed] [Google Scholar]
  • 29. ) Tobioka , H. , Sawada , N. , Zhong , Y. and Mori , M.Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration . Br. J. Cancer , 74 , 439 – 445 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. ) Satoh , H. , Zhong , Y. , Isomura , H. , Saitou , M. , Enomoto , K. , Sawada , N. and Mori , M.Localization of 7H6 tight junction‐associated antigen along the cell border of vascular endothelial cells correlates with paracellular barrier function against ions, large molecules, and cancer cells . Exp. Cell Res. , 222 , 269 – 274 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Jiang , G. , Nepomuceno , L. , Hopkins , K. and Sladek , F. M.Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors . Mol. Cell. Biol. , 15 , 5131 – 5143 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. ) Jiang , G. and Sladek , F. M.The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor a . J. Biol. Chem. , 272 , 1218 – 1225 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Gossen , M. , Freundlieb , S. , Bender , G. , Muller , G. , Hillen , W. and Bujard , H.Transcriptional activation by tetracyclines in mammalian cells . Science , 268 , 1766 – 1769 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Osanai , M. , Ogawa , K. and Lee , G. H.Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c‐myc expression: characterization of an unexpected effect . Cancer Res. , 57 , 2896 – 2903 ( 1997. ). [PubMed] [Google Scholar]
  • 35. ) Hertz , R. , Magenheim , J. , Berman , I. and Tana , J.Fatty acyl‐CoA thioesters are ligands of hepatic nuclear factor–4alpha . Nature , 392 , 512 – 516 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Al‐Mehdi , A. B. , Tozawa , K. , Fisher , A. B. , Shientag , L. , Lee , A. and Muschel , R. J.Intravascular origin of metastasis from proliferation of endothelium‐attached tumor cells: a new model for metastasis . Nat. Med. , 6 , 100 – 102 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Weiss , L.Metastatic inefficiency . Adv. Cancer Res. , 54 , 159 – 211 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 38. ) Wong , C. W. , Lee , A. , Shientag , L. , Yu , J. , Dong , Y. , Kao , G. , Al‐Mehdi , A. B. , Bernhard , E. J. and Muschel , R. J.Apoptosis: an early event in metastatic inefficiency . Cancer Res. , 61 , 333 – 338 ( 2001. ). [PubMed] [Google Scholar]
  • 39. ) Latinis , K. M. , Norian , L. A. , Eliason , S. L. and Koretzky , G. A.Two NFAT transcription binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells . J. Biol. Chem. , 272 , 31427 – 31434 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 40. ) Le‐Niculescu , H. , Bonfoco , E. , Kasuya , Y. , Claret , F. X. , Green , D. R. and Karin , M.Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death . Mol. Cell. Biol. , 19 , 751 – 763 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. ) Zhang , J. , Ma , B. , Marshak‐Rothstein , A. and Fine , A.Characterization of a novel cis‐element that regulates Fas ligand expression in corneal endothelial cells . J. Biol. Chem. , 274 , 26537 – 26542 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 42. ) Peiler , G. , Bockmann , B. , Nakhei , H. and Ryffel , G. U.Inhibitor of the tissue‐specific transcription factor HNF4, a potential regulator in early Xenopus development . Mol. Cell. Biol. , 20 , 8676 – 8683 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. ) Kägi , D. , Vignaux , F. , Ledemann , B. , Burki , K. , Depraetere , V. , Nagata , S. , Hengartner , H. and Golstein , P.Fas and perform pathways as major mechanisms of T cell‐mediated cytotoxicity . Science , 265 , 528 – 530 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 44. ) McGahon , A. J. , Nishioka , W. K. , Martin , S. J. , Mahboubi , A. , Cotter , T. G. and Green , D. R.Regulation of the Fas apoptotic cell death pathway by Abl . J. Biol. Chem. , 270 , 22625 – 22631 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 45. ) Itoh , N. , Tsujimoto , T. and Nagata , S.Effect of bcl–2 on Fas antigen‐mediated cell death . J. Immunol. , 151 , 621 – 627 ( 1993. ). [PubMed] [Google Scholar]
  • 46. ) Weller , M. , Malipiero , U. , Aguzzi , A. , Reed , J. C. and Fontana , A.Protooncogene bcl–2 gene transfer abrogates Fas/APO–1 antibody‐mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation . J. Clin. Invest. , 95 , 2633 – 2643 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. ) Tanaka , M. , Suda , T. , Haze , K. , Nakamura , N. , Sato , K. , Kimura , F. , Motoyoshi , K. , Mizuki , M. , Tagawa , S. , Ohga , S. , Hatake , K. , Drummond , A. H. and Nagata , S.Fas ligand in human serum . Nat. Med. , 2 , 317 – 322 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 48. ) Tanaka , M. , Itai , T. , Adachi , M. and Nagata , S.Deregulation of Fas ligand by shedding . Nat. Med. , 4 , 31 – 36 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 49. ) Schneider , P. , Holler , N. , Bodner , J. L. , Hahne , M. , Frei , K. , Fontana , A. and Tschopp , J.Conversion of membrane‐bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity . J. Exp. Med. , 187 , 1205 – 1213 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. ) Suhara , T. , Fukuo , K. , Sugimoto , T. , Morimoto , S. , Nakahashi , T. , Hata , S. , Shimizu , M. and Ogihara , T.Hydrogen peroxide induces up‐regulation of Fas in human endothelial cells . J. Immunol. , 160 , 4042 – 4047 ( 1998. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES